US dangerous gamble in S. China Sea, tarnishing China’s image to scare ASEAN; S'pore PM keynote address

South China Sea Dispute: Tension escalates between China and U.S

US takes dangerous gamble in S.China Sea

US Defense Secretary Ash Carter on Wednesday claimed that China's actions in the South China Sea would bring countries in the region together in new ways and the US will continue to beef up its engagement in the Asia-Pacific at the increasing demands of those nations. "There should be no mistake in this, the US will fly, sail and operate wherever international law allows," Carter said.

Freedom of flight over and navigation in the South China Sea in no way means that US military planes and vessels can bluntly defy the legal construction activities of China. Based on international law, China will resist any sabotage of its island construction within its own sovereignty and will carry the activities through to the end.

Washington is taking dangerous gamble in the South China Sea. With aggressive US interference, there has been much speculation about the possibility of a US-China military clash in the region. Washington hopes this will convert into pressure on China. It may not expect a compromise from China over island construction, but hopes China would be psychologically burdened in its maritime development.

Is the China-US relationship approaching a tipping point? Some Chinese scholars hold that the US is merely flying a kite. It's testing China's determination and strategy to counterstrike US provocation. It's probable that the US military and diplomatic circles haven't yet reached a consensus. Washington will make the decision after assessing China's reaction.

Nonetheless, Washington has taken a step in displaying its hard-line stance toward China. Some Americans are highly vigilant of China's newly released military strategy white paper, but they can't be unrestrained in showing their anxiety. How could China, the world second-largest economy, neglect maritime security?

China has made it clear that relevant facilities under construction will be used for peaceful regional development and cooperation. The US suspects the sites may be turned into military outposts to confront US maritime hegemony. But those reefs and islets are China's own territory. Blocking China's legitimate actions out of imaginary worries and suspicions is a blunt violation of the norms of international relations and diplomatic principles.

At a time when China is having strong momentum of development and seeking external cooperation for implementing the "One Belt, One Road" initiative, it's unnecessary for China to divert attention by building military outposts.

The dangerous provocation of the US, driven by their illusion of the worst-case scenario, is unwise and reckless. It is pressing Beijing to act in compliance with Washington's desire. However, China won't dance to the rhythm of the US.

US tarnishing China’s image to scare ASEAN

The 14th Asia Security Summit, known as the Shangri-La Dialogue, opened Friday in Singapore. US Defense Secretary Ashton Carter and the Chinese People's Liberation Army's deputy chief of staff Sun Jianguo will both give speeches there. The South China Sea issue is expected to be the focus point of this annual meeting.

Before Carter arrived in Singapore, he made strong remarks about China, claiming that China's land reclamation in the South China Sea will push countries in this region to join hands with the US. It is becoming an increasingly prominent theme for the US in its efforts to drive a wedge into the cooperation between China and the ASEAN countries.

It is true that territory disputes exist in the South China Sea. But the region has the capability to digest the disputes gradually. The blunt interference by the US is worsening the South China Sea disputes. The risk of friction between China and the US over the sea is rising.

China is ASEAN's largest trade partner, while ASEAN is China's third largest trade partner. Cooperation between China and ASEAN is the foundation of regional prosperity. The US is losing in the competition for economic cooperation in this region. It is desperately trying to find a way to fill in this gap.

Regional countries such as the Philippines and Vietnam need outside powers to balance a regional power. The US has been taking advantage of their interests in this regard.

Now China is painted as a pursuer of regional hegemony, and the monitoring of China's attempts to artificially expand islets in the South China Sea have become landmark moves to put a hold on China's supposed hegemonic efforts.

This is a situation that Washington is pleased to see. But China and ASEAN countries will have to pay the prices for the US pivot to the Asia-Pacific.

Some are worried that China may use the expanded islets as outposts for military aggression against neighboring countries. But such confrontations are not in China's interest. China's latest "One Belt, One Road" initiative promotes developing trade with countries, including those along the "maritime silk road."

The biggest challenge for China is to find a difficult and subtle balance between its own national interests and regional peace. Some countries wish China to sacrifice its own interests for regional peace. This is unrealistic.

We emphasize an Asia of the Asians, because we believe only Asians really care about Asia's peace and stability, and still remembers the pains of past turmoil. The US will not take responsibility for Asia's prosperity, let alone sacrifice itself for Asian countries. ASEAN countries must be clear about this

Source:Global Times Published: 2015-5-29 & 30 Posted in: Editorial

Related
 

Hope lies beyond Sino-Japanese stalemate

Onus on US to cool South China Sea heat

White paper aims at PLA transparency

 

 China exercises 'maximum restraint' on South China Sea issues

While China has a firm resolve to defend the country's national sovereignty, maritime rights and interests, it advocates solving disputes through negotiation and maintains "maximum restraint".

 Ambassador Cui Tiankai’s Interview with the Wall Street Journal on South China SeaOn May 28, 2015, Ambassador Cui Tiankai had an interview with Mr. Adam Horvath, World Editor of the Wall Street Journal. The following is 

Related posts:

Who owns the South China Sea islets in the eyes of the world?

Apr 24, 2012

She stated on July 23, 2010 at the ASEAN meeting in Hanoi: "Legitimate claims to maritime space in the South China Sea should be derived SOLELY from legitimate claims to land features." Translation: Why China has claim ...

 
Singapore Prime Minister Lee Hsien Loong Keynote Address at Shangri-La Dialogue 2015 

 

Malaysian Strata Management Act 2013 will be enforced from June 1, 2015 in Penang

Cheers for high-rise house buyers

GEORGE TOWN: The state government has endorsed the Strata Management Act 2013 (Act 757) which will be enforced from June 1.

In making the announcement, State Housing, Town and Country Planning Committee chairman Jagdeep Singh Deo said the new Act was introduced to replace Act 663 or the Building and Common Property (Maintenance and Management) Act 2007.

It was reported that the new law allows both the landlords and tenants to be brought to court, compared to the previous Act which only allowed action to be taken against the landlord.

Gazetted in 2013 but still awaiting all states in Malaysia to endorse it, the Act streamlines the issuance of strata title and makes it faster for an owner to obtain it from the housing developer.

Besides this, it will impose higher penalties for non-compliance, put more responsibilities on the housing developer for the strata buildings and make sure the management of strata properties is more responsible.

Chief Minister Lim Guan Eng said the Act would ensure that application for strata titles, the management of buildings and the issues involved would be eased.

“The state exco decided today to give its endorsement so that there will be no disruption to application for strata titles.

“At the same time, we decided to show our willingness to cooperate with the Federal Government by endorsing the Strata Management Act which was approved by the state exco just now during our meeting.

“This means that Penang will be a part of the national implementation of the new Act,” he told a press conference in Komtar yesterday.

Lim added that the endorsement was important as around 60% of housing on the island were stratified units. - The Star/Asia News Network

Related post:

 
Regulate property management! Forum on Strata Management in Penang...
Regulate property management! Forum on Strata Management in Penang. IT is understandable for the Strata Management Act to attract much public interest. There are (or will soon be) more people living in high-rise strata ...



New beginning in Malaysian strata property management ? 
Good property management, maintenance add value 25 Nov 2012
Is property building management a professional? 08 Nov 2012
Managing strata properties in Malaysia Sep 11, 2012
World's Simplest Management Secret 08 Nov 2012   

Counterfeit medicines and drugs, a public health menance !

Fake medicines may contain toxic substances that include heavy metals (e.g. aresenic) and additives (e.g. steroids). – AFP

The drugs you are taking may be fake

Counterfeit drugs are a booming criminal industry with serious consequences for public health.

Many of us have a strong faith in the power of modern medicine.

We go to the doctor or pharmacist, get the prescribed pills, take them religiously and expect to be cured of whatever ails us.

Oftentimes, this faith is justified, but in an age where fake products abound, have you ever wondered about the authenticity and quality of the drugs that you are ingesting?

According to a 2013 Emerging Markets Health Network report, 3-5% of all medicines being circulated in Malaysia were fakes.

Health Minister Datuk Seri Dr S. Subramaniam has also been reported as saying that the ministry had seized some 33,704 unregistered products worth RM43.22mil last year alone.

While this is not high compared to other middle- and low-income countries – for example, the International Pharmaceutical Manufacturers Group in Indonesia estimates that about one-quarter of medicines on the Indonesian market are fake – it is certainly something to be worried about as it concerns our health.

University of Oxford’s Reader in Tropical Medicine, Prof Dr Paul Newton says that it is difficult to estimate the global size of the problem as there is not enough data.

According to him, there are very few studies, and very few of those are done in a scientifically-rigorous manner, adding that there are certainly hotspots of such problems around the world.

Pfizer Global Security director Mark Robinson shares that the pharmaceutical company sees the highest number of fake drug seizures in Asia, compared to the rest of the world.

But he adds: “That’s because we are targeting (illegal) labs, seizing the drugs before they reach the market.” He observes that in 60 countries around the world, patients went into a legitimate, licensed pharmacy and got counterfeit drugs.

In addition, he notes that the World Health Organisation (WHO) estimates that over half of those who buy drugs online from unverified websites receive counterfeit medicines.

Two types of fake

Fake drugs, also called poor quality drugs, can be divided into two types: counterfeit and substandard.

Prof Newton explains that counterfeit medicines are made by criminals with the intent to deceive patients and healthcare workers for monetary gain.

According to Robinson, these criminals include entrepreneurs, terrorist organisations, drug syndicates and weapons dealers.

 Brick dust, used to hold the fake pill together, as well as boric acid, leaded highway paint to provide the yellow colour, and floor wax to provide shine, were found to be used in the production of counterfeit mefenamic acid by an illegal lab in Colombia. - AFP

They do it, he says, because it is profitable, because they are pretty sure they won’t get caught, and because even if they do get caught, the penalties are very low compared to the amount of money they can make.

The danger of these drugs is that they can vary from not having any active pharmaceutical ingredient to containing toxic materials. (See What’s in your fake drug)

Active pharmaceutical ingredients are the chemical compounds that treat the medical condition.

Unlike counterfeit drugs, substandard drugs are made by the original or licensed manufacturer, but do not conform to the proper standard of quality.

They are “medicines with mistakes”, says Prof Newton.

These medicines occur due to errors in the factories. Sometimes, they can be small errors, and sometimes, they can be large errors, like using the wrong active ingredient, he says.

He opines that this problem is more likely to occur in low-income countries where there is a lack of drug regulation and quality control measures.

However, as with counterfeit drugs, it is difficult to estimate the size of this problem due to the lack of data.

“Not many people are actually looking (for this problem), so we might have an unpleasant surprise,” he says, adding that in terms of public health, substandard medicines are as dangerous as counterfeit drugs.

He adds that some companies are very active in ensuring that their products are good, but, like any human activity, some cut corners and skip the quality control.

Poor regulation

According to the WHO, only one-fifth of its member states have well-developed drug regulation; half have varying levels of regulation and enforcement; and the remaining 30% have either very limited or no drug regulation at all.

In Malaysia, Dr Subramaniam was reported as saying that online drug sales are a particularly hard area to enforce as the Customs Department does not screen packages valued below RM500, due to the very high number of such packages.

“We have asked the Customs Department to screen all packages, and they are trying to do it, but I think it is quite expensive to put such a system in place,” he said after opening the Access to Safe Medicines Training Conference organised by Mediharta Sdn Bhd in January.

Prof Newton was a speaker at the same conference, while Robinson was a speaker at the launch of Pfizer’s anti-counterfeit technology, Patient Authentication for Safety via SMS (PASS), in Malaysia.

According to Robinson, the top three drugs produced by Pfizer that are found to be counterfeited in Malaysia are erectile dysfunction drug, sildenafil; non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation, celecoxib; and hypertension drug, amlodipine.

He adds that it is not only branded drugs that are counterfeited, but also generic drugs that are no longer patented, like the NSAID mefenamic acid.

“People just want to use our good name (to sell fake drugs),” he says.

Prof Newton notes that antibiotics and cardiovascular drugs are also being increasingly counterfeited in South-East Asia.

He adds that it is not only drugs that are counterfeited, but also medical devices like cardiac stents, rapid diagnostic tests and insecticide-treated bed nets – a problem particularly rampant in Africa.

Bad effects

The effects of fake drugs can be felt both on the individual level, as well as on a wider scale. For the patient, taking counterfeit drugs can range from death to developing more serious health complications.

These health complications may be caused by the actual illness being untreated due to a lack of active ingredients in the counterfeit drug, or the drug containing either toxic ingredients or the wrong active ingredients.

The latter will also make it more complicated for doctors to treat the patients, as they might be confused by the incongruent symptoms.

Counterfeit or substandard drugs that contain less active ingredients than required can also cause drug resistance, particularly if they are antibiotics.

Prof Newton adds that consuming fake drugs also ends up incurring more expense on the patients’ part, as they don’t get better and keep on buying more medications.

Patients might also lose faith in the healthcare system, he says. “If you don’t trust the pharmaceutical companies or doctors, you won’t go back and might seek other alternatives.

He notes that fake drugs will also affect genuine pharmaceutical companies, as well as government healthcare systems and non-governmental organisations that inadvertently purchase these drugs.

Both Prof Newton and Robinson hope that governments around the world will take a stronger stance against counterfeit medicines, both in terms of enacting relevant legislation with much stronger penalties for those producing fake drugs, as well as in terms of enforcement.

Patients should also be more careful of what they consume.

For example, signs that a medicine could be fake include an excessively low price, flimsy or unprofessional packaging, and not requiring a doctor’s or pharmacist’s prescription for non-OTC (over the counter) drugs.


An example of the holographic security label for registered Malaysian drugs, which features the hibiscus symbol, serial number and the letters PBKD and DCA. All drug packaging must have this label. – Photo:
An example of the holographic security label for registered Malaysian drugs, which features the hibiscus symbol, serial number and the letters PBKD and DCA. All drug packaging must have this label. – Photo: Health Ministry

In Malaysia, registered drugs also have a holographic security sticker on their packaging.

By Tan Shiow Chin The Star/Asia News Network

Related:

The counterfeit menace - Health